Kraton Corporation (KRA)

Common Stock

46.49  +0.01 (+0.02%)

After market: 46.48 -0.01 (-0.02%)

Fundamental Rating

2

Taking everything into account, KRA scores 2 out of 10 in our fundamental rating. KRA was compared to 84 industry peers in the Chemicals industry. KRA may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, KRA is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

In the past year KRA was profitable.
Of the past 5 years KRA 4 years were profitable.
Each year in the past 5 years KRA had a positive operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA 7.66%
ROE 25.51%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 12.93%
PM (TTM) 8.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The number of shares outstanding for KRA has been increased compared to 1 year ago.
KRA has a better debt/assets ratio than last year.

2.2 Solvency

KRA has an Altman-Z score of 2.15. This is not the best score and indicates that KRA is in the grey zone with still only limited risk for bankruptcy at the moment.
KRA has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z 2.15
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

KRA has a Current Ratio of 1.64. This is a normal value and indicates that KRA is financially healthy and should not expect problems in meeting its short term obligations.
KRA has a Quick Ratio of 1.64. This is a bad value and indicates that KRA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.75

5

3. Growth

3.1 Past

KRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 121.71%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.01% on average over the past years.
The Revenue has grown by 54.01% in the past year. This is a very strong growth!
KRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.47% yearly.
EPS 1Y (TTM)121.71%
EPS 3Y-3.17%
EPS 5Y4.01%
EPS growth Q2Q347.83%
Revenue 1Y (TTM)54.01%
Revenue growth 3Y-0.69%
Revenue growth 5Y2.47%
Revenue growth Q2Q25.95%

3.2 Future

Based on estimates for the next years, KRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.27% on average per year.
Based on estimates for the next years, KRA will show a small growth in Revenue. The Revenue will grow by 1.89% on average per year.
EPS Next Y12.54%
EPS Next 2Y9.58%
EPS Next 3Y11.84%
EPS Next 5Y13.27%
Revenue Next Year-0.57%
Revenue Next 2Y2.13%
Revenue Next 3Y1.8%
Revenue Next 5Y1.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.26, the valuation of KRA can be described as correct.
When comparing the Price/Earnings ratio of KRA to the average of the S&P500 Index (28.06), we can say KRA is valued slightly cheaper.
KRA is valuated correctly with a Price/Forward Earnings ratio of 14.44.
When comparing the Price/Forward Earnings ratio of KRA to the average of the S&P500 Index (20.72), we can say KRA is valued slightly cheaper.
Industry RankSector Rank
PE 16.26
Fwd PE 14.44

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.15

4.3 Compensation for Growth

KRA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.3
PEG (5Y)4.06
EPS Next 2Y9.58%
EPS Next 3Y11.84%

0

5. Dividend

5.1 Amount

KRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Kraton Corporation

NYSE:KRA (3/14/2022, 8:12:45 PM)

After market: 46.48 -0.01 (-0.02%)

46.49

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.50B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.26
Fwd PE 14.44
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.3
PEG (5Y)4.06
Profitability
Industry RankSector Rank
ROA 7.66%
ROE 25.51%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.93%
PM (TTM) 8.45%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.64
Quick Ratio 0.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)121.71%
EPS 3Y-3.17%
EPS 5Y
EPS growth Q2Q
EPS Next Y12.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)54.01%
Revenue growth 3Y-0.69%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y